INTRAVENOUS USTEKINUMAB REINDUCTION IS EFFECTIVE IN PRIOR BIOLOGIC REFRACTORY PATIENTS WITH CROHN'S DISEASE ALREADY ON 4 WEEKLY DOSING: A REAL-WORLD CASE SERIES

Rocio Sedano  1     Leonard Guizzetti  2     Cassandra McDonald  3     Vipul Jairath  3    
1 Western University & London Health Sciences Centre, London, Canada
2 Robarts Clinical Trials Inc, London, Canada
3 Lawson Health Research Institute, Western University, London, Canada

Session
IBD (Posters)

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing